Cargando…

Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature

We report a patient with multiple endocrine neoplasia type 1 with pancreatic polypeptide (PP) secreting subcentimeter pancreatic neuroendocrine tumors (pNETs) treated with octreotide and review the current literature that pertains to the management of these patients. Clinical data, laboratory result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kemm, Matthew H., Manly, Cory D., Hoang, Thanh D., Mai, Vinh Q., Shakir, Mohamed K. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515007/ https://www.ncbi.nlm.nih.gov/pubmed/31183223 http://dx.doi.org/10.1155/2019/9462942

Ejemplares similares

Diarrhea as an Initial Presentation in Patients with Medullary Thyroid Cancer: Delaying the Diagnosis
por: Shakir, Mohamed K.M., et al.
Publicado: (2020)

Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization
por: Shakir, Mohamed K.M., et al.
Publicado: (2020)

SUN-595 Chronic Diarrhea as a Manifestation of Medullary Thyroid Cancer
por: Shakir, Mohamed, et al.
Publicado: (2019)

Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
por: Exner, Samantha, et al.
Publicado: (2018)

R-CHOP-Associated Graves' Hyperthyroidism
por: Mora, Natalie, et al.
Publicado: (2019)

Coexistence of Cushing Disease With a Solitary Adrenocorticotrophic Hormone-Dependent Adrenal Adenoma
por: Shakir, Mohamed K.M., et al.
Publicado: (2020)

Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and Plasmapheresis
por: Nguyen, Nguyen T., et al.
Publicado: (2021)

SUN-206 Acute Cardiovascular Complications FromTestosterone Therapy
por: Shakir, Mohamed, et al.
Publicado: (2019)

THU521 A Case Of Multifocal Pancreatic Neuroendocrine Tumor With Multiple Twists
por: Syeda, Asma, et al.
Publicado: (2023)

Multifocal pancreatic PPoma in the setting of MEN1: Case report and review of literature
por: Mosenia, Arman, et al.
Publicado: (2021)

Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review
por: Al Bulushi, Naima, et al.
Publicado: (2019)

Benign-Appearing Glucagonoma Undergoing Malignant Transformation after a Prolonged Period
por: Shakir, Mohamed K.M., et al.
Publicado: (2020)

SUN-001 Identification of Dehydroepiandrosterone-s (DHEA-s) Elevation Due to Performance Enhancing Supplements
por: Shin, Terry, et al.
Publicado: (2020)

The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide.
por: Kvols, L. K., et al.
Publicado: (1992)

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
por: Yau, Hanford, et al.
Publicado: (2017)

E4206: AMG 706 and Octreotide in Patients with Low‐Grade Neuroendocrine Tumors
por: Lubner, Sam, et al.
Publicado: (2018)

SUN-170 Adrenal Insufficiency Due to Adrenal Hemorrhage
por: Bansal, Rashika, et al.
Publicado: (2020)

Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors
por: Cheng, Yue, et al.
Publicado: (2023)

SAT-363 Renal Papillary Necrosis Associated with Normocalcemic Hyperparathyroidism
por: Shakir, Mohamed K M, et al.
Publicado: (2020)

Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis
por: Ryan, P, et al.
Publicado: (2019)

Refractory Thrombocytopenia Responds to Octreotide Treatment in a Case of Evans Syndrome with Gastric Neuroendocrine Tumor
por: Chung-Delgado, Kocfa, et al.
Publicado: (2013)

The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
por: Li, Su-Chen, et al.
Publicado: (2012)

First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor
por: Nath, Ermin, et al.
Publicado: (2020)

Low-Dose Prednisone Therapy is Efficacious in Treating Painful Subacute Thyroiditis
por: Shakir, Mohamed K M, et al.
Publicado: (2021)

Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour
por: Abell, Sally K, et al.
Publicado: (2015)

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis
por: Strosberg, Jonathan R, et al.
Publicado: (2015)

Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors
por: Zhang, Zhouwei, et al.
Publicado: (2020)

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
por: Berruti, Alfredo, et al.
Publicado: (2014)

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors
por: Saif, Muhammad Wasif, et al.
Publicado: (2018)

Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours
por: Koumarianou, Anna, et al.
Publicado: (2012)

MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors: MEN1 promotes ferroptosis in pancreatic neuroendocrine tumors
por: Ye, Zeng, et al.
Publicado: (2022)

Octreotide and hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2007)

Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma)
por: Hiraide, Sakura, et al.
Publicado: (2017)

Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2016)

Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism
por: Shakir, Mohamed K M, et al.
Publicado: (2021)

Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors
por: Takeda, Yasutaka, et al.
Publicado: (2017)

Desiccated Thyroid Extract Versus Synthetic LT4/T3 Combination Versus LT4 Monotherapy in the Treatment of Primary Hypothyroidism With Special Attention to the Thr92AlaD2 Polymorphism. With Special Attention to the Gene Polymorphism
por: Hoang, Thanh Duc, et al.
Publicado: (2021)

Laparoscopic Pylorus- and Spleen-Preserving Duodenopancreatectomy for a Multifocal Neuroendocrine Tumor
por: Schlöricke, Erik, et al.
Publicado: (2015)

Somatostatin-receptor avidity of pancreatic neuroendocrine tumor thrombus in porto-caval venous systems on (99m)Tc-Octreotide and posttherapeutic (177)Lu-DOTA-TATE scans
por: Amoui, Mahasti, et al.
Publicado: (2021)

Response to Letter to the Editor From Bonnema et al: “Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine + Liothyronine in Hypothyroidism”
por: Shakir, Mohamed K M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eonnbsai2qc29l6a6g7p416od3